Phase 3 Study of KW-6500 (Placebo-Controlled Double-Blind Crossover Comparative Study in Patients With Parkinson's Disease).
Phase of Trial: Phase III
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 12 Dec 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 12 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.